Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1447 record(s)

Req # A-2023-001243

The number of applications for exemption under subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) to possess and use psilocybin that were received by the Minister of Health in 2021, 2022 and 2023. The number of exemptions under subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) to possess and use psilocybin that were issued by the Minister of Health in 2021, 2022 and 2023.

Organization: Health Canada

2 page(s)
February 2024

Req # A-2023-001244

The number of requests filed by medical practitioners on behalf of their patients to access psilocybin through Health Canada's Special Access Program (SAP) for emergency treatment of their patient in 2022, 2023, and 2024. The number of requests filed by medical practitioners on behalf of patients identifying as men and/or male to access psilocybin through Health Canada's Special Access Program (SAP) for emergency treatment of their patient in 2022, 2023, and 2024. The number of requests filed by medical practitioners on behalf of patients identifying as female and/or women to access psilocybin through Health Canada's Special Access Program (SAP) for emergency treatment of their patient in 2022, 2023, and 2024. The number of Special Access Program (SAP) requests filed by medical practitioners on behalf of their patients to access psilocybin for emergency treatment of their patient that were granted and/or approved in 2022, 2023, and 2024. The number of Special Access Program (SAP) requests filed by medical practitioners on behalf of patients identifying as men and/or male to access psilocybin for emergency treatment of their patient that were granted and/or approved in 2022, 2023, and 2024. The number of Special Access Program (SAP) requests filed by medical practitioners on behalf of patients identifying as female and/or women to access psilocybin for emergency treatment of their patient that were granted and/or approved in 2022, 2023, and 2024.

Organization: Health Canada

2 page(s)
February 2024

Req # A-2023-001290

Statistical tables of drug losses and thefts reported to Health Canada from hospitals, veterinary hospitals, cancer centres, First Nations health centres, university health centres, drug treatment centres and any other entity that must report such losses to Health Canada. Reports for all of Canada. Between January 1, 2018 and December 31, 2023.

Organization: Health Canada

54999 page(s)
February 2024

Req # A-2023-001337

Names of all Health Canada Media Relations staff employed in the National Capital Region on January 24, 2024; Names of all Media Relations staff on duty that day thru the office associated with the Media Contact telephone number 613-957-2983; Name(s) of Media Relations staff who authored email(s) sent thru the account Media@hc-sc.gc.ca with the subject heading "Correction Needed" on January 24, 2024 between 9 am and 4 pm Eastern.

Organization: Health Canada

1 page(s)
February 2024

Req # A-2023-001344

Provide records showing your agency’s annual spending on advertising during the fiscal years of 2019-2020 to 2022-2023, and partial fiscal year 2023-2024 until the end of December 2023.

Organization: Health Canada

1 page(s)
February 2024

Req # A-2023-00391

Information between 25 April 2023 and 13 June 2023, pertaining to Member of Parliament, Dan Mazier’s Order Paper Question No. Q-1451

Organization: Innovation, Science and Economic Development Canada

95 page(s)
February 2024

Req # A-2023-00576

BN0017200: Letter Regarding Grocery

Organization: Innovation, Science and Economic Development Canada

45 page(s)
February 2024

Req # A-2023-00602

BN0016674: Government Response to INDU Committee - Blockchain Technology: Cryptocurrencies and Beyond

Organization: Innovation, Science and Economic Development Canada

32 page(s)
February 2024

Req # A-2023-00603

BN0016676: Réponse du gouvernement à la comité INDU - Domestic Manufacturing Capacity for a COVID-19 Vaccine

Organization: Innovation, Science and Economic Development Canada

49 page(s)
February 2024

Req # A-2023-00615

BN0016031: Tabling of the 2023-2027 Copyright Board of Canada’s Departmental Sustainable Development Strategy

Organization: Innovation, Science and Economic Development Canada

41 page(s)
February 2024
Date modified: